Moderna says its Omicron shots provide better protection than original COVID-19 jab - National Globalnews.ca In the news

Topics

Change location

TV Programs

Connect

your local region

All event types Comedy Festival Food Health Music Sports Theatre Virtual Other

Quick Search

Trending Now

Want to discuss? Please read our first. Advertisement Close X

Moderna says its Omicron shots provide better protection than original COVID-19 jab

Omicron-tailored shots, mRNA-1273.214 and mRNA-1273.222, produced a higher antibody response against BA.4/5 sub-variants than its original shot in vaccinated and boosted adults, the company said. Moderna, however, said levels of neutralizing antibody response dropped nearly five-fold against the emerging sub-variant BQ.1.1 when compared with BA.4/5, in an analysis of about 40 participants, although the virus neutralizing activity still remained “robust.” Rival Pfizer Inc. and its German partner, BioNTech, said earlier this month their Omicron-tailored shot targeting the BA.4/5 sub-variants produced a strong antibody response in older adults than the original shot after one month. Story continues below advertisement Based on data from preclinical studies, Omicron-tailored shots made by Moderna and Pfizer have already been approved in the United States for adults as well as for children as young as five years. According to government data, nearly 31.4 million Americans had received the updated shot as of Nov. 9, with around 5.1 million getting vaccinated last week. © 2022 Reuters

Sponsored content

Advertisement Stay in the loop Get a roundup of the most important and intriguing national stories delivered to your inbox every weekday. Sign Up

Trending

Top Videos

Stay in the loop Get a roundup of the most important and intriguing national stories delivered to your inbox every weekday. Sign Up Advertisement

Flyers